* Merit Medical Systems Inc MMSI.OQ MMSI.O is expected
to show
a rise in quarterly revenue when it reports results on April
26.
* The South Jordan Utah-based company is expected to report
a
1.8% increase in revenue to $280.446 million from $275.42
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data. The company's guidance on
February 22 2023, for the period ended March 31, was for revenue
between $278.17 million and $283.68 million.
* Refinitiv's mean analyst estimate for Merit Medical
Systems Inc
is for earnings of 55 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Merit
Medical
Systems Inc is $78.5, below its last closing price of $79.00.
The company's guidance on February 22 2023 for the period ended
March 31 was for gross profit margin between USD44.79% and
USD45.79%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 0.67 0.67 0.79 Beat 17.7
Sep. 30 2022 0.53 0.53 0.64 Beat 21.1
Jun. 30 2022 0.58 0.58 0.73 Beat 26.3
Mar. 31 2022 0.47 0.47 0.53 Beat 13.9
Dec. 0.51 0.52 0.71 Beat 36.5
31 2021
Sep. 30 2021 0.44 0.44 0.52 Beat 19.2
Jun. 30 2021 0.45 0.44 0.62 Beat 39.7
Mar. 31 2021 0.36 0.36 0.52 Beat 45.4
This summary was machine generated April 25 at 00:46 GMT. All
figures in US dollars unless otherwise stated